Greater Cannabis Company (GCAN) Other Accumulated Expenses (2017 - 2026)

Greater Cannabis Company's Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $268600.0 for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 3.31% year-over-year to $268600.0 in Q1 2026; TTM through Mar 2026 was $268600.0, a 3.31% increase from a year earlier, with the FY2025 full-year figure at $263600.0, up 1.38% from the prior year.
• Other Accumulated Expenses improved to $268600.0 in Q1 2026 per GCAN's latest filing, from $263600.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $268600.0 in Q1 2026 and bottomed at $260000.0 in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $260000.0 (2022), against an average of $260871.4.
• Across the five-year window, Other Accumulated Expenses changed 0.0% in 2023 and climbed 3.31% in 2026, its largest moves.
• Year by year, Other Accumulated Expenses stood at $260000.0 in 2022, then changed by 0.0% to $260000.0 in 2023, then changed by 0.0% to $260000.0 in 2024, then climbed by 1.38% to $263600.0 in 2025, then gained by 1.9% to $268600.0 in 2026.
• Per Business Quant, the three latest GCAN Other Accumulated Expenses figures stand at $268600.0 (Q1 2026), $263600.0 (Q4 2025), and $260000.0 (Q3 2025).